0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R5,000 - R10,000 (2)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Erythrocytes as Drug Carriers in Medicine (Hardcover, 1997 ed.): Ulrich Sprandel, James L. Way Erythrocytes as Drug Carriers in Medicine (Hardcover, 1997 ed.)
Ulrich Sprandel, James L. Way
R5,275 Discovery Miles 52 750 Ships in 10 - 17 working days

The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy."

Erythrocytes as Drug Carriers in Medicine (Paperback, Softcover reprint of the original 1st ed. 1997): Ulrich Sprandel, James... Erythrocytes as Drug Carriers in Medicine (Paperback, Softcover reprint of the original 1st ed. 1997)
Ulrich Sprandel, James L. Way
R5,118 Discovery Miles 51 180 Ships in 10 - 17 working days

The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In deed, clinical trials were initiated to evaluate the dose-response curves employing L asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy."

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Airway Mucus: Basic Mechanisms and…
D.F. Rogers, M. I. Lethem Hardcover R5,214 Discovery Miles 52 140
The First Forty Days - The Essential Art…
Heng Ou, Amely Greeven, … Hardcover  (1)
R588 R555 Discovery Miles 5 550
Integrating Lifestyle Medicine for…
Michael Via, Jeffrey Mechanick Paperback R1,478 Discovery Miles 14 780
Race, Sex, and the Freedom to Marry…
Peter Wallenstein Hardcover R2,113 Discovery Miles 21 130
How to Manage a Mammoth - A book for…
Rose Stewart Paperback R208 Discovery Miles 2 080
Truth - The Kordell Stewart Story
Kordell Stewart Paperback R346 R325 Discovery Miles 3 250
Capitalist Crusader - Fighting Poverty…
Herman Mashaba Paperback R300 R277 Discovery Miles 2 770
Dragon Ball Super, Vol. 5
Akira Toriyama Paperback  (1)
R256 R232 Discovery Miles 2 320
WTF - Capturing Zuma: A Cartoonist's…
Zapiro Paperback R295 R272 Discovery Miles 2 720
Economics for Nonprofit Managers and…
Dennis R. Young, Richard Steinberg, … Paperback R1,125 Discovery Miles 11 250

 

Partners